| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | -0.023 | 0.7 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.026 | 0.7 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.02 | 0.7 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.7 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | -0.022 | 0.7 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.02 | 0.7 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |